Sanofi Faces 1st US Suit Over Likely Carcinogen In Zantac
A Florida man with breast cancer has accused Zantac maker Sanofi Aventis US LLC of knowingly selling a medication that contained a probable carcinogen in the first suit of its type...To view the full article, register now.
Already a subscriber? Click here to view full article